Amdocs Limited (NASDAQ:DOX) Shares Sold by Inceptionr LLC

Inceptionr LLC lowered its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 40.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,682 shares of the technology company's stock after selling 10,039 shares during the period. Inceptionr LLC's holdings in Amdocs were worth $1,250,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Raymond James Financial Inc. purchased a new stake in shares of Amdocs during the 4th quarter worth $44,494,000. Proficio Capital Partners LLC acquired a new stake in Amdocs in the fourth quarter valued at $1,906,000. Seizert Capital Partners LLC lifted its holdings in Amdocs by 9.3% during the 4th quarter. Seizert Capital Partners LLC now owns 536,074 shares of the technology company's stock worth $45,641,000 after buying an additional 45,419 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Amdocs by 3.1% during the 4th quarter. Victory Capital Management Inc. now owns 493,047 shares of the technology company's stock worth $41,978,000 after acquiring an additional 14,910 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Amdocs by 3.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 213,310 shares of the technology company's stock worth $18,161,000 after acquiring an additional 6,173 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Remove Ads

Amdocs Stock Performance

NASDAQ DOX traded up $0.03 on Monday, reaching $90.49. The stock had a trading volume of 956,280 shares, compared to its average volume of 665,024. The stock has a market cap of $10.22 billion, a P/E ratio of 21.00, a price-to-earnings-growth ratio of 1.47 and a beta of 0.68. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $93.83. The business's 50-day moving average price is $86.36 and its 200 day moving average price is $86.97. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. As a group, equities analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be given a dividend of $0.527 per share. This is a boost from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 annualized dividend and a yield of 2.33%. Amdocs's payout ratio is presently 48.72%.

Wall Street Analysts Forecast Growth

DOX has been the topic of several research analyst reports. Oppenheimer boosted their target price on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th. Finally, Barclays lowered their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Amdocs has an average rating of "Moderate Buy" and an average target price of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.